Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who are hospitalised at the Martinique University Hospital for treatment or monitoring of a moderate or severe traumatic brain injury (a serious head injury, measured by a standard medical score of 13 or below at the time of first treatment)
- People whose brain scan shows a specific type of bleeding around the brain (called subarachnoid haemorrhage)
- People who have given free, written, and informed consent — or, if they are unable to do so, whose legal representative has given consent on their behalf
- People included under an emergency consent procedure (where a representative could not initially be reached), provided the representative or patient is informed and gives written agreement within the first 48 hours
- People who are enrolled in a social security (health insurance) scheme
Who may not be able to join:
- People who are pregnant
- People who have a known or newly diagnosed aneurysm (a bulge in a blood vessel in the brain)
- People with a known history of severe chronic kidney disease (stage 4, meaning kidney function is significantly reduced — confirm with trial site)
- People for whom death is considered imminent
- People who meet criteria that would prevent admission to critical care — for example, death is expected within 48 hours, a serious life-limiting illness is expected to cause death within 30 days, or the person is receiving palliative (end-of-life comfort) care
- People with a known allergy to iodine-based contrast dye (a substance used in certain medical scans)
- People who are under a legal protection order, guardianship, or curatorship
- People whose representative (or the person themselves) has declined participation in the study
- People whose death becomes expected within the first 48 hours after joining the trial
- People who are under 18 years of age
- People who leave the hospital against medical advice
- People who are transferred to a different hospital before day 13 of treatment
- People whose representative (or the person themselves, after recovery) withdraws consent to participate, including withdrawal of permission to use already-collected data
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marie SABIA, PhD, University Hospital Center of Martinique
Phone: 05 96 55 10 54
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Estimate the incidence of cerebral vasospasm (CV) with clinical impact in moderate to severeTBI patients complicated by subarachnoid hemorrhage (SAH) at Martinique University Hospital.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.